NNovo Nordisk Read More NVO Stock Jumps 4% As European Committee Backs Novo’s Haemophilia Pen2026-09-17 Chief executive Mike Doustdar said the recommendation builds on more than 40 years of haemophilia work. In FRONTIER…
GGreenland Read More Biotech Division of Greenland Mines Announces Issuance of Patent in Canada for the Klotho Gene Therapy Platform Technology for Alzheimer’s and Aging2026-07-28 CHARLOTTE, N.C., July 28, 2026 (GLOBE NEWSWIRE) — via IBN — Greenland Mines Ltd (Nasdaq: GRML) (“Greenland Mines”…
NNovo Nordisk Read More Fangzhou Launches Novo Nordisk’s Once-Weekly Basal Insulin/GLP-1 Therapy in China2026-07-20 SHANGHAI, July 20, 2026 (GLOBE NEWSWIRE) — Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider…
GGreenland Read More Biotech Division of Greenland Mines Announces Australian Patent Grant for Klotho Gene Therapy Technology for Treatment of Neuromuscular Diseases2026-07-10 NEW YORK, July 10, 2026 (GLOBE NEWSWIRE) — via IBN — Greenland Mines Ltd (Nasdaq: GRML) (“Greenland Mines”…
AAmsterdam Read More Amsterdam UMC researchers overturn long-standing biological pacemaker dogma2026-06-11 Researchers from Amsterdam UMC have overturned a key assumption in the biological pacemaker field. In a new preclinical…
NNovo Nordisk Read More Novo Nordisk’s oral semaglutide demonstrates potential to be the first oral GLP-1 RA therapy for children and adolescents with type 2 diabetes2026-04-23 PIONEER TEENS is the first clinical trial of an oral GLP-1 RA therapy in children and adolescents aged…
CCopenhagen Read More the Danish addiction to winter swimming2026-02-14 CopenhagenBirgitte Thorup Nielsen (67 years old) carefully descends the icy stairs to avoid slipping. The sea water is…